Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 3
2005 5
2006 2
2007 1
2008 6
2009 5
2010 8
2011 11
2012 12
2013 8
2014 13
2015 14
2016 14
2017 20
2018 28
2019 27
2020 25
2021 25
2022 25
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean liuwei wang[Author] (53 results)?
Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy.
Zhou Q, Tu X, Hou X, Yu J, Zhao F, Huang J, Kloeber J, Olson A, Gao M, Luo K, Zhu S, Wu Z, Zhang Y, Sun C, Zeng X, Schoolmeester KJ, Weroha JS, Hu X, Jiang Y, Wang L, Mutter RW, Lou Z. Zhou Q, et al. Among authors: wang l. Drug Resist Updat. 2024 Apr 16;74:101085. doi: 10.1016/j.drup.2024.101085. Online ahead of print. Drug Resist Updat. 2024. PMID: 38636338
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer.
Alkhatib H, Conage-Pough J, Roy Chowdhury S, Shian D, Zaid D, Rubinstein AM, Sonnenblick A, Peretz-Yablonsky T, Granit A, Carmon E, Kohale IN, Boughey JC, Goetz MP, Wang L, White FM, Kravchenko-Balasha N. Alkhatib H, et al. Among authors: wang l. Mol Cancer. 2024 Jan 16;23(1):17. doi: 10.1186/s12943-023-01921-9. Mol Cancer. 2024. PMID: 38229082 Free PMC article.
Identification of a Notch transcriptomic signature for breast cancer.
Braune EB, Geist F, Tang X, Kalari K, Boughey J, Wang L, Leon-Ferre RA, D'Assoro AB, Ingle JN, Goetz MP, Kreis J, Wang K, Foukakis T, Seshire A, Wienke D, Lendahl U. Braune EB, et al. Among authors: wang l. Breast Cancer Res. 2024 Jan 3;26(1):4. doi: 10.1186/s13058-023-01757-7. Breast Cancer Res. 2024. PMID: 38172915 Free PMC article.
Age-Dependent Sex Differences in the Prevalence of Selective Serotonin Reuptake Inhibitor Treatment: A Retrospective Cohort Analysis.
Sanchez-Ruiz JA, Leibman NI, Larson NB, Jenkins GD, Ahmed AT, Nunez NA, Biernacka JM, Winham SJ, Weinshilboum RM, Wang L, Frye MA, Ozerdem A. Sanchez-Ruiz JA, et al. Among authors: wang l. J Womens Health (Larchmt). 2023 Nov;32(11):1229-1240. doi: 10.1089/jwh.2022.0484. Epub 2023 Oct 19. J Womens Health (Larchmt). 2023. PMID: 37856151
Syk-dependent alternative homologous recombination activation promotes cancer resistance to DNA targeted therapy.
Zhou Q, Tu X, Hou X, Yu J, Zhao F, Huang J, Kloeber J, Olson A, Gao M, Luo K, Zhu S, Wu Z, Zhang Y, Sun C, Zeng X, Schoolmeester K, Weroha J, Wang L, Mutter R, Lou Z. Zhou Q, et al. Among authors: wang l. Res Sq [Preprint]. 2023 Jun 9:rs.3.rs-2922520. doi: 10.21203/rs.3.rs-2922520/v1. Res Sq. 2023. PMID: 37333340 Free PMC article. Updated. Preprint.
Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors.
Tang X, Thompson KJ, Kalari KR, Sinnwell JP, Suman VJ, Vedell PT, McLaughlin SA, Northfelt DW, Aspitia AM, Gray RJ, Carter JM, Weinshilboum R, Wang L, Boughey JC, Goetz MP. Tang X, et al. Among authors: wang l. Breast Cancer Res. 2023 May 24;25(1):57. doi: 10.1186/s13058-023-01656-x. Breast Cancer Res. 2023. PMID: 37226243 Free PMC article.
254 results